TP53 and pancreatic ductal adenocarcinoma: Mass spectrometry analysis revealed that the loss of p53 in pancreatic ductal adenocarcinoma (PDAC) cells leads to a significant reduction in lysophospholipids, sphinganine, and phosphatidylglycerol, which may influence the tumor microenvironment and immune response.